Proggio Aids Global Pharma Company in Delivering Life-Changing Medicine

Proggio gives Amryt Pharma clarity and visibility in complex supply chain and manufacturing processes, streamlining procurement, testing and production for its rare disease treatments.

Company

Founded in 2015, Amryt Pharma is a global pharmaceutical company providing hope to those who need it most. Specializing in rare disease treatments, the company develops and delivers innovative medicines that transform the lives of people with debilitating, but uncommon, diseases. Headquartered in Dublin, Ireland, its global infrastructure includes manufacturing, licensing partnerships and business operations across Europe and North and South America.

Challenge

Amryt’s drug development, testing and manufacturing process is extremely complex. During drug development, there are R&D, testing and clinical trials to manage. At the production stage, every batch of every drug made is essentially treated as a new product, in which the raw materials, supply planning, sample testing, manufacturing, shipping and distribution must be meticulously tracked and accounted for across multiple SKUs and multiple production facilities. One product might go through four different manufacturing steps, each at a different location. And each starting material may feed into multiple different SKUs, adding further complexity to the tracking.

“It’s a lot to digest and it’s very time consuming to manage,“ said Ronit Ofer, Supply Chain Project Manager.

With more than 20 years in pharma supply chain/procurement, Ronit is no stranger to the complexity, but she knew her Excel spread sheets were hardly up to the challenge.

“Every batch is a new project, therefore there are a lot of lines for each batch. With Excel, there’s no way to know if a certain CMO has extended the timelines, how that affects the readiness of that batch or see the implications that has for accessibility for patients.”

Solution

Ronit saw a friend post a link to Proggio, the adaptive project portfolio management platform that offers real-time clarity and agility across the entire project portfolio. She immediately saw it as a potential solution to her dilemma, offering better visibility, the ability to work across global teams and adapt timelines on-the-fly when needed. 

“Proggio offers a graphical way to view the status of every project, and it’s live, so it’s much easier to communicate to stakeholders versus just showing a static list of all the dates,” she said. “With Proggio, it’s easier to visualize where we are now, and whether we’ll achieve our intended timelines.”

As an added bonus, Proggio’s copy-and-paste feature makes it easy for Ronit to build a manufacturing scheme for all four of Amryt’s products, and then duplicate that template, changing only the lot numbers, SKUs and dates. This makes it much easier to get started on each new batch/project and saves a tremendous amount of time.

Results

With Proggio, Amryt is able to track each and every part of the drug development, testing and manufacturing process with precision and clarity. 

Its built-in dependency logic gives the Amryt team the option to link projects together that are dependent on one another—for example, the clinical trials using the batch currently being manufactured. This clear visibility allows the company to see the expected outcomes, identify any hurdles and see the implications of any decisions that might change the project plan across dependent projects.

“I recommend Proggio to a lot of my colleagues,” Ronit said. “I always recommend it to anyone I hear working on project management, and these days, that’s just about everyone—from supply chain and procurement to product development and manufacturing. It’s a great tool with a lot of benefits and it helps to reduce the stress of staying on top of so many moving parts in a project.”

To learn more about how Proggio’s adaptive solution can bring visibility, clarity and strategic focus to project portfolio management in your organization, visit www.proggio.com.